Clinical trials
Observational Obesity trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 13 |
| Completed | 11 |
| Recruiting | 7 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 8 |
| Rijnstate Hospital | 4 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Amsterdam UMC, location VUmc | 2 |
| Catharina Ziekenhuis Eindhoven | 1 |
| Children's & Women's Health Centre of British Columbia | 1 |
| HAN University of Applied Sciences | 1 |
| Julius Clinical | 1 |
| Leiden University Medical Center | 1 |
| Maastricht University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 35 |
| Overweight | 12 |
| Diabetes Mellitus | 6 |
| Hypertension | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Cardiovascular Diseases | 3 |
| Pediatric Obesity | 3 |
| Weight Loss | 3 |
| Fatty Liver | 2 |
| Insulin Resistance | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.